» Articles » PMID: 23148628

The Future of Thiopurine Pharmacogenomics

Overview
Specialties Genetics
Pharmacology
Date 2012 Nov 15
PMID 23148628
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease.

Zakerska-Banaszak O, Lykowska-Szuber L, Walczak M, Zuraszek J, Zielinska A, Skrzypczak-Zielinska M Toxics. 2022; 10(4).

PMID: 35448412 PMC: 9026123. DOI: 10.3390/toxics10040151.


Thiopurine pharmacogenomics and pregnancy in inflammatory bowel disease.

Andoh A, Kawahara M, Imai T, Tatsumi G, Inatomi O, Kakuta Y J Gastroenterol. 2021; 56(10):881-890.

PMID: 34287682 DOI: 10.1007/s00535-021-01805-z.


6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities.

Swaim C, Perng Y, Zhao X, Canadeo L, Harastani H, Darling T bioRxiv. 2020; .

PMID: 32637945 PMC: 7337375. DOI: 10.1101/2020.07.01.183020.


Exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers.

Chua E, Cree S, Barclay M, Doudney K, Lehnert K, Aitchison A Pharmacogenomics J. 2015; 15(5):414-21.

PMID: 25752523 DOI: 10.1038/tpj.2015.9.


Enhanced specificity of TPMT*2 genotyping using unidirectional wild-type and mutant allele-specific scorpion primers in a single tube.

Chen D, Yang Z, Xia H, Huang J, Zhang Y, Jiang T PLoS One. 2014; 9(4):e91824.

PMID: 24705376 PMC: 3976262. DOI: 10.1371/journal.pone.0091824.